Liesl Gildea, MSc

Associate Director, Market Access and Outcomes Strategy
Liesl Gildea
Practice Area:
Therapeutic Expertise:
Manchester, United Kingdom

MSc, Healthcare Management
BSc, Health and Sports Studies
University of Huddersfield, Huddersfield, United Kingdom

Liesl Gildea, MSc, is a Senior Research Associate in the Market Access and Outcomes Strategy group and is based in RTI-HS’s office in Manchester, UK. In her current role, Mrs Gildea is involved in primary and secondary research to support the development of evidence-based dossiers, systematic and targeted literature reviews, health technology assessment submissions (including Nordic submissions), and health economics and outcomes research strategies.  She has experience in a range of therapy areas, including cardiovascular disease, oncology, respiratory disease, ulcerative colitis, COVID-19, and medical devices. Before joining RTI-HS, Mrs Gildea was a Health Technology Assessment Analyst at the National Institute for Health and Care Excellence (NICE), specialising in the evaluation of medical devices for use in the UK’s National Health Service (NHS).